Solutions

Clinical solutions

Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions

Consulting & Commercial

Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data

Case studies
Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

Technologies
Technology solutions from early phase through to post-marketing.
Sectors

Sectors

ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

Read more

Biotech Government and Public Health Medical Device Pharmaceuticals

Biotech
Developing transformative therapies requires a flexible approach.

ICON and You
Partners making a difference.
Therapeutics

Therapeutics

Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology

Cross-therapeutics

Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health

Obesity
A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

Therapeutics insights
ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
Insights

Insights

Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel

Building a comparative evidence base using network meta-analysis
Methods, implementation and reporting

Download 2025 Global and China biotech sector survey reports
Two new reports of surveys of 260+ Global and China biotech leaders have just been released

From bottlenecks to breakthroughs
Human-centred strategies for faster study starts
News & Events

News & Events

ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

Read more

Press releases In the News Mediakit Awards Events Webinars Social media

ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change
Watch the webinar.

Riding the data wave: How pharma can navigate disruptions in open claims
Watch the webinar.
About ICON

About ICON

Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality

ICON for

Patients Volunteers Investigators Jobs & Careers Investors Suppliers

Sustainability, charity, inclusion and belonging
ICON Cares is our commitment to making a positive impact on our people, environment and our community.

ICON at a glance
Delivering successful outcomes across the clinical development lifecycle.

Careers
Investors
Contact
日本語
简体中文

Home
News & Events
Social media

Social media

Showing 661 - 672 of 955 results for "*"

ICON will be participating in ACOP 2025 in Aurora, Colorado, where we will introduce Yi Zhang, our new Scientific Director of PK in the Pharmacometrics Department. Yi brings extensive expertise in PK/PD modeling, disea...

15 Oct

ICON Plc

What does successful biomarker integration look like in early-phase CNS trials? Discover how leading researchers are applying imaging, wet, genetic, and digital biomarkers to enrich populations and improve decision-maki...

15 Oct

ICON Plc

One billion people worldwide will be living with obesity by 2030. Connect with us at Obesity Week, booth #520 on Nov 4–7 to learn how ICON supports obesity trials with market intelligence, regulatory expertise, and ready...

15 Oct

ICON Plc

Meet ICON at #ObesityWeek, Nov 4–7 at booth \#520 to arrange time with our experts and explore how we support next-gen obesity trials. From proof of concept to large portfolios, ICON delivers market intelligence and read...

15 Oct

ICON Plc

ICON invites you to attend a presentation by Arjen Akkerman, Senior Director, Accelerated Pharmaceutical Solutions on 28 October at 11:35 am at Messe Frankfurt. In his session, “From collaboration to commitment: Strengt...

This October, ICON will be in Copenhagen as a proud sponsor of the #OCTNordics conference, taking place on the 21st and 22nd. We invite you to stop by booth #41 to meet our team and discover how ICON is partnering with ...

15 Oct

ICON Plc

This October, ICON will be in Copenhagen as a proud sponsor of the #OCTNordics conference, taking place on the 21st and 22nd. We invite you to stop by booth \#41 to meet our team and discover how ICON is partnering with...

15 Oct

ICON Plc

Meet ICON’s experts at #ESMO25, booth #3034 to discuss how our extensive testing capabilities, clinical research experience and scientific expertise can support global oncology and haematology research programmes. https:...

15 Oct

ICON Plc

Meet ICON’s experts at #ESMO25, booth \#3034 to discuss how our extensive testing capabilities, clinical research experience and scientific expertise can support global oncology and haematology research programmes. https...

15 Oct

ICON Plc

In oncology, a single biomarker usually is not enough to provide useful information about a patient’s cancer or response to treatment, and the relationships between individual biomarkers can be difficult to establish or ...

15 Oct